Eli Lilly BDCL
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

Type of Study:
Trial evaluates 2 dose schedules for LY3209590 in comparison to daily insulin Degludec

Study Length:
26 Weeks

Target Age/Sex:
over 18 years, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Staus: Closed

Description:

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

This Study is Closed.